In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...
Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...
BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...
Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.
In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...